TrueBlue (TBI) Common Equity (2009 - 2026)

TrueBlue (TBI) has reported Common Equity for 18 consecutive years, with $254.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 16.56% year-over-year to $254.7 million in Q2 2026; TTM through Jun 2026 was $254.7 million, a 16.56% decrease from a year earlier, with the FY2025 full-year figure at $274.6 million, down 12.94% from the prior year.
• Common Equity was $254.7 million for Q2 2026 at TrueBlue, down from $256.1 million in the prior quarter.
• Over five years, Common Equity peaked at $496.3 million in Q4 2022 and troughed at $254.7 million in Q2 2026.
• A 5-year average of $382.0 million and a median of $392.1 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity grew 4.92% in 2022 and plunged 32.29% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $496.3 million in 2022, then declined by 7.75% to $457.9 million in 2023, then tumbled by 31.13% to $315.4 million in 2024, then declined by 12.94% to $274.6 million in 2025, then decreased by 7.24% to $254.7 million in 2026.
• The last three Common Equity figures came in at $254.7 million (Q2 2026), $256.1 million (Q1 2026), and $274.6 million (Q4 2025), per Business Quant data.